Barchart.com
[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:
Faster, Cleaner, Better.

Telo Genomics Corp (TDSGF)

Telo Genomics Corp (TDSGF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
Telo Genomics Grants Stock Options Newsfile - Tue Aug 4, 5:38AM CDT

Vancouver, British Columbia--(Newsfile Corp. - August 4, 2026) - Telo Genomics Corp. (TSXV: TELO) (OTCQB: TDSGF) (the "Company" or "Telo Genomics"), a leader in the development of diagnostic and prognostic...

TDSGF : 0.0352 (+34.87%)
TELO.VN : 0.045 (unch)
Telo Genomics Provides Positive Interim Data from Ongoing Clinical Trial Advancing Genomic Instability-Based Relapse Risk Assessment Newsfile - Thu Jul 16, 6:10AM CDT

Clinical Study on Track to Meet Primary Endpoints with Interim Data Demonstrating Blood-Based Assay Capable of Predicting Relapse Risk Through Analysis of Genomic Instability and Telomere ArchitectureVancouver,...

TDSGF : 0.0352 (+34.87%)
TELO.VN : 0.045 (unch)
Telo Genomics Files Patent to Expand IP Portfolio to Liquid Biopsy MRD Applications for Multiple Myeloma Newsfile - Thu Jul 9, 6:08AM CDT

Toronto, Ontario--(Newsfile Corp. - July 9, 2026) - Telo Genomics Corp. (TSXV: TELO) (OTCQB: TDSGF) (the "Company" or "Telo"), a leader in diagnostic and prognostic innovation through advanced telomere...

TDSGF : 0.0352 (+34.87%)
TELO.VN : 0.045 (unch)
Telo Genomics Announces Termination of Investor Relations Agreement Newsfile - Fri Jun 26, 8:00PM CDT

Vancouver, British Columbia--(Newsfile Corp. - June 26, 2026) - Telo Genomics Corp. (TSXV: TELO) (OTCQB: TDSGF) (the "Company" or "Telo Genomics"), a leader in the development of diagnostic and prognostic...

TDSGF : 0.0352 (+34.87%)
TELO.VN : 0.045 (unch)
Telo Genomics Announces Study with University of Athens to Advance Next-Generation MRD Risk Stratification in Multiple Myeloma Newsfile - Tue Apr 14, 6:00AM CDT

Clinical Trial Seeks to Validate Novel Blood-Based Assay that Predicts Relapse Risk by Analyzing the Biologic Behavior of Remaining Cancer Cells, Addressing Critical Gaps in Current Minimal Residual Disease...

TDSGF : 0.0352 (+34.87%)
TELO.VN : 0.045 (unch)
Telo Genomics Announces Appointment of John Farlinger as CEO and Chairman Newsfile - Tue Mar 31, 6:06AM CDT

Vancouver, British Columbia--(Newsfile Corp. - March 31, 2026) - Telo Genomics Corp. (TSXV: TELO) (OTCQB: TDSGF) (the "Company" or "Telo Genomics"), a leader in the development of diagnostic and prognostic...

TDSGF : 0.0352 (+34.87%)
TELO.VN : 0.045 (unch)
Telo Genomics Announces Appointment of John Price as Chief Financial Officer Newsfile - Thu Jan 29, 7:04AM CST

Toronto, Ontario--(Newsfile Corp. - January 29, 2026) - Telo Genomics Corp. (TSXV: TELO) (OTCQB: TDSGF) (the "Company" or "Telo Genomics") a leader in the development of diagnostic and prognostic tests...

TDSGF : 0.0352 (+34.87%)
TELO.VN : 0.045 (unch)
Telo Genomics Launches Retrospective Blood-Based MRD Study with University of Athens as Part of 2026 Multi-Center Validation Program Newsfile - Thu Dec 18, 2025

Toronto, Ontario--(Newsfile Corp. - December 18, 2025) - Telo Genomics Corp. (TSXV: TELO) (OTCQB: TDSGF) (the "Company" or "Telo"), a leader in diagnostic and prognostic innovation through advanced telomere...

TDSGF : 0.0352 (+34.87%)
TELO.VN : 0.045 (unch)
Telo Genomics Presents Genomic Profiles of Peripheral Blood Minimal Residual Disease Cells at the 67th American Society of Hematology Meeting Newsfile - Thu Dec 11, 2025

Toronto, Ontario--(Newsfile Corp. - December 11, 2025) - Telo Genomics Corp. (TSXV: TELO) (OTCQB: TDSGF) (the "Company" or "Telo") a leader in the development of diagnostic and prognostic tests for human...

TDSGF : 0.0352 (+34.87%)
TELO.VN : 0.045 (unch)
Telo Genomics to Present Groundbreaking Individual-Cell Risk Assessment MRD Technology at the Myeloma Canada MRD Implementation Summit 2025 Newsfile - Thu Nov 13, 2025

Toronto, Ontario--(Newsfile Corp. - November 13, 2025) - Telo Genomics Corp. (TSXV: TELO) (OTCQB: TDSGF) ("Telo" or the "Company"), a leader in diagnostic and prognostic innovation through its proprietary...

TDSGF : 0.0352 (+34.87%)
TELO.VN : 0.045 (unch)

Barchart Exclusives

TurboTax Maker Intuit Leads 3 Cheap, Dividend-Paying Tech Stocks With Up to 151% Upside Barchart - Fri Aug 14, 6:00PM CDT
Intuit is one of three cheap, dividend-paying tech stocks flying under the radar, with Wall Street price targets suggesting up to 151% upside for the software giant. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.